TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.40$ +6.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Exagen Inc (XGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 58 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XGN
Line item 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
16 17 15 20 29 88 78 123 86 57 45 58
8.0 5.1 3.9 13 21 81 71 113 73 48 36 49
7.7 4.6 2.5 11 13 72 57 99 62 36 22 32
7.7 4.6 2.5 11 13 72 57 99 62 36 22 32
0.1 0.6 6.0 5.7 8.9 9.7 6.1 6.6 7.8 11
0.0 0.0 0.5 1.0 1.4 1.2 1.1 1.8 2.9
1.2 1.5 1.6 1.3 1.6 1.4 2.1 4.8 13
5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 0.0
1.0 0.8 0.5 0.1 0.0 5.5 5.5 5.5
16 31 37 25 36 33 37 39 44 34 35 41
11 26 35 5.0 9.0 5.9 8.8 9.3 9.6 12 14 14
8.9 19 26 0.0 0.1 0.2 0.3 0.6 1.9 1.2 1.7 3.0
0.4 1.8 2.2 1.8 1.3 1.5 3.0 2.5 3.0 3.1 4.1 4.2
0.0 0.0 19 25 26 27 27 29 19 20 22
0.5 -14 -22 -4.6 -6.7 56 42 85 42 23 9.5 17
-74 -89 -108 -148 -153 -165 -181 -208 -256 -279 -294 -314
0.1 0.1 0.1 0.1 0.1 13 13 16 17 18 18 22

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?